SkinHealth Systems Inc. SKIN R2K

Consumer Defensive · Household & Personal Products · United States

https://www.skinhealthsystems.com

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Market & Price

Market Cap

$100.28M

Current Price

$0.77

High / Low (52W)

$2.63 / $0.58

Beta

1.12

Valuation

Stock P/E

Industry PE

18.88

Forward P/E

5.16

PEG Ratio

0.93

Book Value

$0.48

Price to Book

1.62

P/S

0.34

EV/EBITDA

19.01

Dividend Yield

Profitability & Returns

ROCE

4.27%

ROE

-11.95%

ROA

-1.15%

Profit Margin

-2.04%

Op Margin

-2.77%

EPS (Latest Qtr)

$-0.05

EPS (TTM)

$-0.13

Balance Sheet & Liquidity

Debt/Equity

6.65

Quick Ratio

1.43

Current Ratio

1.79

Debt

$367.13M

Total Assets

$499.80M

Current Assets

$309.52M

Working Capital

$123.24M

Ownership

Promoter Holding

13.19%

Chg in Prom Hold

FII / Inst Holding

87.91%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$265.06M

Total Revenue (TTM)

$296.12M

EBITDA

$13.94M

Free Cash Flow

$28.42M

Operating Cash Flow

$28.93M

Shares Outstanding

129.60M

Gross Margin

64.91%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-6.32%

Profit 5Y

-40.51%

Revenue (YoY)

-6.70%

Earnings (YoY)

PROS

Generates positive free cash flow.

CONS

Revenue declined at -6.3% CAGR over 5 years.
Earnings shrank at -40.5% CAGR over 5 years.
Trading 70.6% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SKIN SkinHealth Systems Inc. R2K	0.77	-	$100.28M	-	4.27%	-11.95%	-6.32%	-40.51%
2	WMT Walmart Inc. SPX	115.75	40.76	$922.64B	0.86%	18.21%	24.13%	5.27%	23.30%
3	COST Costco Wholesale Corporation NDXSPX	956.32	49.76	$424.27B	0.61%	27.44%	29.65%	6.64%	11.49%
4	KO The Coca-Cola Company SPX	79.01	24.85	$339.94B	2.68%	21.13%	43.37%	3.69%	11.16%
5	PG The Procter & Gamble Company SPX	143.56	21.02	$334.29B	2.97%	23.63%	31.11%	1.67%	2.71%
6	PM Philip Morris International Inc. SPX	177.38	24.98	$276.46B	3.31%	35.35%	-	8.57%	7.84%
7	PEP PepsiCo, Inc. NDXSPX	144.19	22.64	$197.10B	4.11%	15.23%	43.88%	2.83%	-2.57%
8	MO Altria Group, Inc. SPX	69.58	14.53	$116.19B	6.09%	40.85%	-	-0.89%	6.42%
9	MNST Monster Beverage Corporation NDXSPX	88.08	42.55	$86.14B	-	28.33%	26.65%	9.54%	16.94%

Quarterly Results

Figures in USD.

Metric	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	14.12M	34.56M	47.54M	66.51M	68.15M	75.42M	103.54M	88.79M	86.28M	117.48M	97.41M	81.40M	90.59M	78.80M	69.58M	78.19M	70.66M	82.37M	64.91M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.00M	29.07M	25.02M	29.33M	20.47M
Gross Profit	-	4.28M	20.96M	31.74M	47.25M	46.08M	50.88M	70.04M	61.36M	54.10M	67.88M	-12.55M	48.36M	40.94M	40.65M	48.58M	49.11M	45.63M	53.04M	44.44M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	60.60M	51.81M	51.88M	52.88M	46.24M
Operating Income	-	-7.92M	2.79M	2.38M	-26.35M	-5.46M	-14.01M	-5.03M	-4.35M	-17.31M	-13.15M	-82.10M	-16.99M	-22.11M	-21.52M	-12.02M	-2.70M	-6.24M	162.00K	-1.80M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-542.00K	28.26M	4.10M	6.92M	4.87M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.50M	4.14M	6.31M	6.37M	6.35M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9.20M	18.72M	-10.64M	-4.81M	-6.81M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	892.00K	-993.00K	386.00K	3.30M	-184.00K
Net Income	-9.07M	-10.40M	-2.21M	-3.27M	-139.38M	-215.15M	31.45M	6.32M	-81.00K	-20.26M	3.36M	-73.82M	-679.00K	202.00K	-18.29M	-10.10M	19.71M	-11.03M	-8.10M	-6.63M
Diluted EPS	-	-0.30	-0.06	-0.09	-1.52	-1.63	-0.13	-0.06	-0.03	-0.15	0.03	-0.56	-0.10	-0.10	-0.15	-0.08	0.03	-0.09	-0.06	-0.05
R&D Expense	-	597.00K	577.00K	1.45M	2.99M	1.88M	2.23M	2.60M	2.17M	2.34M	2.88M	1.84M	2.81M	1.16M	1.11M	998.00K	1.25M	1.70M	-	1.10M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	166.62M	119.09M	260.09M	365.88M	397.99M	334.29M	300.79M
Cost of Revenue	-	-	-	117.10M	242.88M	152.00M	104.43M
Gross Profit	106.51M	67.20M	178.54M	248.78M	155.11M	182.30M	196.36M
Operating Expenses	-	-	-	274.62M	286.03M	250.07M	217.17M
Operating Income	13.46M	-17.18M	-39.93M	-25.84M	-130.92M	-67.77M	-20.80M
EBITDA	-	-	-	81.60M	-53.56M	14.54M	38.74M
Interest Expense	-	-	-	13.39M	13.65M	10.41M	19.33M
Pretax Income	-	-	-	45.34M	-101.89M	-29.55M	-5.94M
Tax Provision	-	-	-	1.11M	-1.77M	-452.00K	3.58M
Net Income	-1.64M	-29.18M	-378.76M	44.22M	-100.12M	-29.10M	-9.52M
Diluted EPS	-0.05	-0.85	-3.71	0.23	-0.76	-0.23	-0.16
R&D Expense	4.61M	3.41M	8.20M	8.44M	10.10M	6.30M	5.63M

Compounded Sales Growth

5 Years:	-6.32%
1 Year:	-6.70%

Compounded Profit Growth

5 Years:	-40.51%
1 Year:	-

Stock Price Performance

1 Year:	-52.52%
6 Months:	-43.91%
3 Months:	-25.58%
1 Month:	-3.73%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	222.84M	-	1.00B	929.11M	685.68M	499.80M
Current Assets	-	-	-	-	783.27M	698.25M	477.12M	309.52M
Cash & Equivalents	-	-	9.49M	-	568.20M	523.02M	370.06M	232.67M
Inventory	-	-	-	-	109.66M	91.32M	69.11M	48.01M
Receivables	-	-	-	-	76.49M	54.70M	27.64M	21.74M
Total Liabilities	-	-	252.79M	-	836.03M	869.72M	633.88M	438.75M
Current Liabilities	-	-	30.93M	-	71.71M	115.01M	68.15M	186.28M
Long Term Debt	-	-	-	-	734.14M	738.37M	552.20M	240.43M
Total Debt	-	-	-	-	751.79M	752.29M	568.16M	378.76M
Total Equity	294.00K	-1.21M	-30.57M	-	167.05M	59.39M	51.80M	61.06M
Shares Outstanding	-	-	-	-	132.21M	122.90M	124.92M	127.52M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	1.73M	-12.44M	-	-106.60M	21.75M	16.13M	37.48M
Investing Cash Flow	-12.48M	-3.82M	-	-18.87M	-31.51M	-6.79M	-5.16M
Financing Cash Flow	14.58M	18.27M	-	-205.24M	-37.45M	-158.34M	-174.93M
Capital Expenditure	-8.77M	-3.50M	-	-17.39M	-13.05M	-6.79M	-5.16M
Free Cash Flow	-7.05M	-15.94M	-	-123.99M	8.70M	9.34M	32.32M
Net Change in Cash	-	-	-	-330.71M	-47.20M	-149.00M	-142.60M
Share Buybacks	0	154.00K	0	160.00M	30.16M	0	0

Ratios (Annual)

Figures in %.

Metric	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	63.9%	56.4%	68.6%	68.0%	39.0%	54.5%	65.3%
Operating Margin %	8.1%	-14.4%	-15.4%	-7.1%	-32.9%	-20.3%	-6.9%
Net Margin %	-1.0%	-24.5%	-145.6%	12.1%	-25.2%	-8.7%	-3.2%
ROE %	135.6%	95.4%	-	26.5%	-168.6%	-56.2%	-15.6%
ROCE %	-	-9.0%	-	-2.8%	-16.1%	-11.0%	-6.6%

Shareholding Pattern

Insiders

13.19%

Institutions

87.91%

Public Float

101.27%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Capricorn Fund Managers Ltd	14.97%	19.40M	$15.01M
2	FMR, LLC	13.26%	17.18M	$13.30M
3	Blackrock Inc.	5.68%	7.36M	$5.69M
4	Millennium Management Llc	4.41%	5.72M	$4.42M
5	Woodline Partners LP	4.40%	5.70M	$4.41M
6	Vanguard Capital Management LLC	2.66%	3.44M	$2.66M
7	Geode Capital Management, LLC	1.73%	2.24M	$1.73M
8	Shaw D.E. & Co., Inc.	1.46%	1.90M	$1.47M
9	State Street Corporation	1.45%	1.88M	$1.46M
10	Vanguard Portfolio Management LLC	1.27%	1.65M	$1.28M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SKIN

No recent headlines available.

SKIN · Consumer Defensive